Aumolertinib showed improved PFS in NSCLC and ivonescimab outperforms pembrolizumab in advanced cases. Plus, insights into CAR T-cell therapy and its associated AEs are discussed in relapsed multiple ...

including scientists at MSD – known as Merck & Co in North America – which collaborated with the International Space Station (ISS) National Laboratory to generate crystallised versions of ...

We recently compiled a list of the 8 Unstoppable Stocks That Could Make You Richer. In this article, we are going to take a ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...

Among patients with early triple-negative breast cancer, treatment with Keytruda (pembrolizumab) demonstrated real-world evidence of immune-related adverse effects (irAEs) comparable with KEYNOTE-522, ...

Keytruda (pembrolizumab) is a prescription drug that’s used to treat certain forms of cancer. Keytruda comes as an intravenous (IV) infusion (an injection into your vein given over time ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless of ...

The leak has been ongoing since 2019 in the Russian segment of the International Space Station (ISS) and was the focus of a new report from NASA's Office of the Inspector General (OIG) published ...

Troubleshooting the leaking ISS is ongoing, with NASA and Russia now identifying 50 "areas of concern" and four cracks, according to a media report. NASA and its Russian counterpart have ...

Merck's diversified pipeline includes promising oncology candidates and a new pneumococcal vaccine, but lacks a ready-made Keytruda replacement. Investors should monitor R&D updates closely ...